Industry Research Reports
Home > Reports > Medical Devices & Consumables > Kidney Cancer Diagnosis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Kidney Cancer Diagnosis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 99 Pages
Report ld: 3501708
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Kidney Cancer Diagnosis Market Size(US$)
CAGR 2025-2031
5%
Market Size,2031
USD 750
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 559 million
Market Forecast in 2031(Value)
US$ 750 million
CAGR
5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Kidney Cancer Diagnosis was estimated to be worth US$ 535 million in 2024 and is forecast to a readjusted size of US$ 750 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnosis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Kidney Cancer Diagnosis by region & country, by Type, and by Application.
The Kidney Cancer Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnosis.
MARKET SEGMENTATION
By Company
- Myriad Genetics Inc.
- NeoGenomics Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Rosetta Genomics
- Illumina Inc.
- Abbott Laboratories
- Roche Holding AG
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Immunohistochemical Test
- Complete Blood Count Test
- Urine Test
- Blood Chemistry Test
Segment by Application
- Hospital
- Surgery Center
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Kidney Cancer Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Kidney Cancer Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Kidney Cancer Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Kidney Cancer Diagnosis Product Introduction
1.2 Global Kidney Cancer Diagnosis Market Size Forecast
1.2.1 Global Kidney Cancer Diagnosis Sales Value (2020-2031)
1.2.2 Global Kidney Cancer Diagnosis Sales Volume (2020-2031)
1.2.3 Global Kidney Cancer Diagnosis Sales Price (2020-2031)
1.3 Kidney Cancer Diagnosis Market Trends & Drivers
1.3.1 Kidney Cancer Diagnosis Industry Trends
1.3.2 Kidney Cancer Diagnosis Market Drivers & Opportunity
1.3.3 Kidney Cancer Diagnosis Market Challenges
1.3.4 Kidney Cancer Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Kidney Cancer Diagnosis Players Revenue Ranking (2024)
2.2 Global Kidney Cancer Diagnosis Revenue by Company (2020-2025)
2.3 Global Kidney Cancer Diagnosis Players Sales Volume Ranking (2024)
2.4 Global Kidney Cancer Diagnosis Sales Volume by Company Players (2020-2025)
2.5 Global Kidney Cancer Diagnosis Average Price by Company (2020-2025)
2.6 Key Manufacturers Kidney Cancer Diagnosis Manufacturing Base and Headquarters
2.7 Key Manufacturers Kidney Cancer Diagnosis Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Kidney Cancer Diagnosis
2.9 Kidney Cancer Diagnosis Market Competitive Analysis
2.9.1 Kidney Cancer Diagnosis Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Kidney Cancer Diagnosis Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnosis as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunohistochemical Test
3.1.2 Complete Blood Count Test
3.1.3 Urine Test
3.1.4 Blood Chemistry Test
3.2 Global Kidney Cancer Diagnosis Sales Value by Type
3.2.1 Global Kidney Cancer Diagnosis Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Kidney Cancer Diagnosis Sales Value, by Type (2020-2031)
3.2.3 Global Kidney Cancer Diagnosis Sales Value, by Type (%) (2020-2031)
3.3 Global Kidney Cancer Diagnosis Sales Volume by Type
3.3.1 Global Kidney Cancer Diagnosis Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Kidney Cancer Diagnosis Sales Volume, by Type (2020-2031)
3.3.3 Global Kidney Cancer Diagnosis Sales Volume, by Type (%) (2020-2031)
3.4 Global Kidney Cancer Diagnosis Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Surgery Center
4.2 Global Kidney Cancer Diagnosis Sales Value by Application
4.2.1 Global Kidney Cancer Diagnosis Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Kidney Cancer Diagnosis Sales Value, by Application (2020-2031)
4.2.3 Global Kidney Cancer Diagnosis Sales Value, by Application (%) (2020-2031)
4.3 Global Kidney Cancer Diagnosis Sales Volume by Application
4.3.1 Global Kidney Cancer Diagnosis Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Kidney Cancer Diagnosis Sales Volume, by Application (2020-2031)
4.3.3 Global Kidney Cancer Diagnosis Sales Volume, by Application (%) (2020-2031)
4.4 Global Kidney Cancer Diagnosis Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Kidney Cancer Diagnosis Sales Value by Region
5.1.1 Global Kidney Cancer Diagnosis Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Kidney Cancer Diagnosis Sales Value by Region (2020-2025)
5.1.3 Global Kidney Cancer Diagnosis Sales Value by Region (2026-2031)
5.1.4 Global Kidney Cancer Diagnosis Sales Value by Region (%), (2020-2031)
5.2 Global Kidney Cancer Diagnosis Sales Volume by Region
5.2.1 Global Kidney Cancer Diagnosis Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Kidney Cancer Diagnosis Sales Volume by Region (2020-2025)
5.2.3 Global Kidney Cancer Diagnosis Sales Volume by Region (2026-2031)
5.2.4 Global Kidney Cancer Diagnosis Sales Volume by Region (%), (2020-2031)
5.3 Global Kidney Cancer Diagnosis Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Kidney Cancer Diagnosis Sales Value, 2020-2031
5.4.2 North America Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Kidney Cancer Diagnosis Sales Value, 2020-2031
5.5.2 Europe Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Kidney Cancer Diagnosis Sales Value, 2020-2031
5.6.2 Asia Pacific Kidney Cancer Diagnosis Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Kidney Cancer Diagnosis Sales Value, 2020-2031
5.7.2 South America Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Kidney Cancer Diagnosis Sales Value, 2020-2031
5.8.2 Middle East & Africa Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Kidney Cancer Diagnosis Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Kidney Cancer Diagnosis Sales Value
6.2.1 Key Countries/Regions Kidney Cancer Diagnosis Sales Value, 2020-2031
6.2.2 Key Countries/Regions Kidney Cancer Diagnosis Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Kidney Cancer Diagnosis Sales Value, 2020-2031
6.3.2 United States Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Kidney Cancer Diagnosis Sales Value, 2020-2031
6.4.2 Europe Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Kidney Cancer Diagnosis Sales Value, 2020-2031
6.5.2 China Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.5.3 China Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Kidney Cancer Diagnosis Sales Value, 2020-2031
6.6.2 Japan Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Kidney Cancer Diagnosis Sales Value, 2020-2031
6.7.2 South Korea Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Kidney Cancer Diagnosis Sales Value, 2020-2031
6.8.2 Southeast Asia Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Kidney Cancer Diagnosis Sales Value, 2020-2031
6.9.2 India Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
6.9.3 India Kidney Cancer Diagnosis Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Myriad Genetics Inc.
7.1.1 Myriad Genetics Inc. Company Information
7.1.2 Myriad Genetics Inc. Introduction and Business Overview
7.1.3 Myriad Genetics Inc. Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Myriad Genetics Inc. Kidney Cancer Diagnosis Product Offerings
7.1.5 Myriad Genetics Inc. Recent Development
7.2 NeoGenomics Laboratories
7.2.1 NeoGenomics Laboratories Company Information
7.2.2 NeoGenomics Laboratories Introduction and Business Overview
7.2.3 NeoGenomics Laboratories Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 NeoGenomics Laboratories Kidney Cancer Diagnosis Product Offerings
7.2.5 NeoGenomics Laboratories Recent Development
7.3 Thermo Fisher Scientific Inc.
7.3.1 Thermo Fisher Scientific Inc. Company Information
7.3.2 Thermo Fisher Scientific Inc. Introduction and Business Overview
7.3.3 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product Offerings
7.3.5 Thermo Fisher Scientific Inc. Recent Development
7.4 Sysmex Corporation
7.4.1 Sysmex Corporation Company Information
7.4.2 Sysmex Corporation Introduction and Business Overview
7.4.3 Sysmex Corporation Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sysmex Corporation Kidney Cancer Diagnosis Product Offerings
7.4.5 Sysmex Corporation Recent Development
7.5 Rosetta Genomics
7.5.1 Rosetta Genomics Company Information
7.5.2 Rosetta Genomics Introduction and Business Overview
7.5.3 Rosetta Genomics Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Rosetta Genomics Kidney Cancer Diagnosis Product Offerings
7.5.5 Rosetta Genomics Recent Development
7.6 Illumina Inc.
7.6.1 Illumina Inc. Company Information
7.6.2 Illumina Inc. Introduction and Business Overview
7.6.3 Illumina Inc. Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Illumina Inc. Kidney Cancer Diagnosis Product Offerings
7.6.5 Illumina Inc. Recent Development
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Company Information
7.7.2 Abbott Laboratories Introduction and Business Overview
7.7.3 Abbott Laboratories Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Abbott Laboratories Kidney Cancer Diagnosis Product Offerings
7.7.5 Abbott Laboratories Recent Development
7.8 Roche Holding AG
7.8.1 Roche Holding AG Company Information
7.8.2 Roche Holding AG Introduction and Business Overview
7.8.3 Roche Holding AG Kidney Cancer Diagnosis Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Roche Holding AG Kidney Cancer Diagnosis Product Offerings
7.8.5 Roche Holding AG Recent Development
8 Industry Chain Analysis
8.1 Kidney Cancer Diagnosis Industrial Chain
8.2 Kidney Cancer Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Kidney Cancer Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Kidney Cancer Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Kidney Cancer Diagnosis Market Trends
Table 2. Kidney Cancer Diagnosis Market Drivers & Opportunity
Table 3. Kidney Cancer Diagnosis Market Challenges
Table 4. Kidney Cancer Diagnosis Market Restraints
Table 5. Global Kidney Cancer Diagnosis Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Kidney Cancer Diagnosis Revenue Market Share by Company (2020-2025)
Table 7. Global Kidney Cancer Diagnosis Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Kidney Cancer Diagnosis Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Kidney Cancer Diagnosis Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Kidney Cancer Diagnosis Manufacturing Base and Headquarters
Table 11. Key Manufacturers Kidney Cancer Diagnosis Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Kidney Cancer Diagnosis
Table 13. Global Kidney Cancer Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnosis as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Kidney Cancer Diagnosis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Kidney Cancer Diagnosis Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Kidney Cancer Diagnosis Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Kidney Cancer Diagnosis Sales Market Share in Value by Type (2020-2025)
Table 20. Global Kidney Cancer Diagnosis Sales Market Share in Value by Type (2026-2031)
Table 21. Global Kidney Cancer Diagnosis Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Kidney Cancer Diagnosis Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Kidney Cancer Diagnosis Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Kidney Cancer Diagnosis Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Kidney Cancer Diagnosis Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Kidney Cancer Diagnosis Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Kidney Cancer Diagnosis Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Kidney Cancer Diagnosis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Kidney Cancer Diagnosis Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Kidney Cancer Diagnosis Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Kidney Cancer Diagnosis Sales Market Share in Value by Application (2020-2025)
Table 32. Global Kidney Cancer Diagnosis Sales Market Share in Value by Application (2026-2031)
Table 33. Global Kidney Cancer Diagnosis Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Kidney Cancer Diagnosis Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Kidney Cancer Diagnosis Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Kidney Cancer Diagnosis Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Kidney Cancer Diagnosis Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Kidney Cancer Diagnosis Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Kidney Cancer Diagnosis Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Kidney Cancer Diagnosis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Kidney Cancer Diagnosis Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Kidney Cancer Diagnosis Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Kidney Cancer Diagnosis Sales Value by Region (2020-2025) & (%)
Table 44. Global Kidney Cancer Diagnosis Sales Value by Region (2026-2031) & (%)
Table 45. Global Kidney Cancer Diagnosis Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Kidney Cancer Diagnosis Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Kidney Cancer Diagnosis Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Kidney Cancer Diagnosis Sales Volume by Region (2020-2025) & (%)
Table 49. Global Kidney Cancer Diagnosis Sales Volume by Region (2026-2031) & (%)
Table 50. Global Kidney Cancer Diagnosis Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Kidney Cancer Diagnosis Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Kidney Cancer Diagnosis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Kidney Cancer Diagnosis Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Kidney Cancer Diagnosis Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Kidney Cancer Diagnosis Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Kidney Cancer Diagnosis Sales Volume, (2026-2031) & (K Units)
Table 57. Myriad Genetics Inc. Company Information
Table 58. Myriad Genetics Inc. Introduction and Business Overview
Table 59. Myriad Genetics Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Myriad Genetics Inc. Kidney Cancer Diagnosis Product Offerings
Table 61. Myriad Genetics Inc. Recent Development
Table 62. NeoGenomics Laboratories Company Information
Table 63. NeoGenomics Laboratories Introduction and Business Overview
Table 64. NeoGenomics Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. NeoGenomics Laboratories Kidney Cancer Diagnosis Product Offerings
Table 66. NeoGenomics Laboratories Recent Development
Table 67. Thermo Fisher Scientific Inc. Company Information
Table 68. Thermo Fisher Scientific Inc. Introduction and Business Overview
Table 69. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product Offerings
Table 71. Thermo Fisher Scientific Inc. Recent Development
Table 72. Sysmex Corporation Company Information
Table 73. Sysmex Corporation Introduction and Business Overview
Table 74. Sysmex Corporation Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sysmex Corporation Kidney Cancer Diagnosis Product Offerings
Table 76. Sysmex Corporation Recent Development
Table 77. Rosetta Genomics Company Information
Table 78. Rosetta Genomics Introduction and Business Overview
Table 79. Rosetta Genomics Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Rosetta Genomics Kidney Cancer Diagnosis Product Offerings
Table 81. Rosetta Genomics Recent Development
Table 82. Illumina Inc. Company Information
Table 83. Illumina Inc. Introduction and Business Overview
Table 84. Illumina Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Illumina Inc. Kidney Cancer Diagnosis Product Offerings
Table 86. Illumina Inc. Recent Development
Table 87. Abbott Laboratories Company Information
Table 88. Abbott Laboratories Introduction and Business Overview
Table 89. Abbott Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Abbott Laboratories Kidney Cancer Diagnosis Product Offerings
Table 91. Abbott Laboratories Recent Development
Table 92. Roche Holding AG Company Information
Table 93. Roche Holding AG Introduction and Business Overview
Table 94. Roche Holding AG Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Roche Holding AG Kidney Cancer Diagnosis Product Offerings
Table 96. Roche Holding AG Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Kidney Cancer Diagnosis Downstream Customers
Table 100. Kidney Cancer Diagnosis Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Cancer Diagnosis Product Picture
Figure 2. Global Kidney Cancer Diagnosis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Kidney Cancer Diagnosis Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Kidney Cancer Diagnosis Sales Volume (2020-2031) & (K Units)
Figure 5. Global Kidney Cancer Diagnosis Sales Price (2020-2031) & (US$/Unit)
Figure 6. Kidney Cancer Diagnosis Report Years Considered
Figure 7. Global Kidney Cancer Diagnosis Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Kidney Cancer Diagnosis Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Kidney Cancer Diagnosis Revenue in 2024
Figure 10. Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Immunohistochemical Test Picture
Figure 12. Complete Blood Count Test Picture
Figure 13. Urine Test Picture
Figure 14. Blood Chemistry Test Picture
Figure 15. Global Kidney Cancer Diagnosis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Kidney Cancer Diagnosis Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Kidney Cancer Diagnosis Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Kidney Cancer Diagnosis Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Kidney Cancer Diagnosis Price by Type (2020-2031) & (US$/Unit)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Surgery Center
Figure 22. Global Kidney Cancer Diagnosis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Kidney Cancer Diagnosis Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Kidney Cancer Diagnosis Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Kidney Cancer Diagnosis Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Kidney Cancer Diagnosis Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Kidney Cancer Diagnosis Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Kidney Cancer Diagnosis Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Kidney Cancer Diagnosis Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Kidney Cancer Diagnosis Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Kidney Cancer Diagnosis Sales Volume (%), (2020-2031)
Figure 39. United States Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 45. China Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 47. China Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 57. India Kidney Cancer Diagnosis Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Kidney Cancer Diagnosis Sales Value by Type (%), 2024 VS 2031
Figure 59. India Kidney Cancer Diagnosis Sales Value by Application (%), 2024 VS 2031
Figure 60. Kidney Cancer Diagnosis Industrial Chain
Figure 61. Kidney Cancer Diagnosis Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Kidney Cancer Diagnosis market?
What was the global market size of Kidney Cancer Diagnosis in 2025?
What was the global market size of Kidney Cancer Diagnosis in 2031?
What is the annual compound growth rate of the global Kidney Cancer Diagnosis market size from 2025 to 2031?
Related Reports
Kidney Cancer Diagnosis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney Cancer Diagnosis was estimated to be worth US$ 559 million in 2025 and is projected to reach US$ 784 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 131
USD 3950.00
(Single User License)
Global Kidney Cancer Diagnosis Market Research Report 2026
The global Kidney Cancer Diagnosis market was valued at US$ 559 million in 2025 and is anticipated to reach US$ 784 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 112
USD 2900.00
(Single User License)
Global Kidney Cancer Diagnosis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Kidney Cancer Diagnosis market size was US$ 535 million in 2024 and is forecast to a readjusted size of US$ 750 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 78
USD 4250.00
(Single User License)
Global Kidney Cancer Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Kidney Cancer Diagnosis market is projected to grow from US$ 535 million in 2024 to US$ 750 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 132
USD 4900.00
(Single User License)
Global Kidney Cancer Diagnosis Market Research Report 2025
The global market for Kidney Cancer Diagnosis was valued at US$ 535 million in the year 2024 and is projected to reach a revised size of US$ 750 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-13
Pages: 78
USD 2900.00
(Single User License)
Global Kidney Cancer Diagnosis Market Research Report 2024
The global Kidney Cancer Diagnosis market was valued at US$ 465.5 million in 2023 and is anticipated to reach US$ 686.6 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 83
USD 2900.00
(Single User License)
Kidney Cancer Diagnosis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney Cancer Diagnosis was estimated to be worth US$ 559 million in 2025 and is projected to reach US$ 784 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 131
USD 3950.00 (Single User License)Global Kidney Cancer Diagnosis Market Research Report 2026
The global Kidney Cancer Diagnosis market was valued at US$ 559 million in 2025 and is anticipated to reach US$ 784 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 112
USD 2900.00 (Single User License)Global Kidney Cancer Diagnosis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Kidney Cancer Diagnosis market size was US$ 535 million in 2024 and is forecast to a readjusted size of US$ 750 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 78
USD 4250.00 (Single User License)Global Kidney Cancer Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Kidney Cancer Diagnosis market is projected to grow from US$ 535 million in 2024 to US$ 750 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 132
USD 4900.00 (Single User License)Global Kidney Cancer Diagnosis Market Research Report 2025
The global market for Kidney Cancer Diagnosis was valued at US$ 535 million in the year 2024 and is projected to reach a revised size of US$ 750 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-13
Pages: 78
USD 2900.00 (Single User License)Global Kidney Cancer Diagnosis Market Research Report 2024
The global Kidney Cancer Diagnosis market was valued at US$ 465.5 million in 2023 and is anticipated to reach US$ 686.6 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now